Macrophage migration inhibitory factor in prostatic adenocarcinoma: Correlation with tumor grading and combination endocrine treatment-related changes
- 21 August 2000
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 45 (1) , 51-57
- https://doi.org/10.1002/1097-0045(20000915)45:1<51::aid-pros6>3.0.co;2-9
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Macrophage migration inhibitory factor in the human prostate: Identification and immunocytochemical localizationThe Prostate, 1999
- Characterization of the Role of the Amino-Terminal Proline in the Enzymatic Activity Catalyzed by Macrophage Migration Inhibitory FactorBiochemistry, 1998
- The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomeraseFEBS Letters, 1997
- Identification of Macrophage Migration Inhibitory Factor in Adipose Tissue and Its Induction by Tumor Necrosis Factor-αBiochemical and Biophysical Research Communications, 1997
- MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid‐induced regulator of the immune responseThe FASEB Journal, 1996
- Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localizationFEBS Letters, 1996
- The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.The Journal of Experimental Medicine, 1994
- A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens.Proceedings of the National Academy of Sciences, 1993
- Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.Proceedings of the National Academy of Sciences, 1966
- Mechanism of a Reaction in Vitro Associated with Delayed-Type HypersensitivityScience, 1966